Most are mild. A few are not.
🔑 Key Takeaways
- Most NAD+ side effects are mild and dose-dependent: flushing, nausea, headaches, injection site burning, muscle cramps, and fatigue
- Serious side effects are uncommon but include liver toxicity (nicotinamide at high doses), low platelet counts, chest pain during IV infusion, and severe allergic reactions
- Side effect profile varies significantly by form: niacin causes flushing, nicotinamide causes liver stress at high doses, NR and NMN are generally gentler
- NAD+ does not cause cancer, but it can theoretically support the survival of cancer cells that already exist, so anyone with a personal or family history of cancer should consult a doctor first
- 7 medication classes interact with NAD+: diabetes drugs, blood pressure medications, cancer treatments, blood thinners, antioxidants, antidepressants, and melatonin
- Injectable and IV NAD+ produce faster effects but a more intense side effect pattern (flushing, chest pressure, nausea); slow infusion rates minimize this
- Pregnant or breastfeeding women, active cancer patients, and people on chemotherapy should avoid NAD+ supplementation without physician oversight
NAD+ supplementation is generally well tolerated. For most healthy adults, the side effect profile is mild and manageable. But "generally safe" is not the same as "risk-free," and the specific form you take, the dose you use, and the medications you combine it with all change the picture.
This article covers every documented side effect of NAD+ and its precursors, by form, by dose, and by delivery method, along with the drug interactions, the cancer question, and clear guidance on when to stop and call a doctor.
Are NAD+ Supplements Safe?
The short answer: for healthy adults at standard doses, yes.
Multiple human trials using NAD+ precursors (NMN, NR, nicotinamide, niacin) at doses up to 1,000-2,000mg daily have shown a favorable safety profile over 6-12 weeks. Injectable and IV NAD+ in clinical use since the 2010s has a similar track record when used under medical supervision.
The "but" that matters: long-term safety data beyond 12-24 weeks is limited, certain precursors (especially nicotinamide and niacin) have dose-dependent risks that kick in at higher intakes, and NAD+ has meaningful interactions with several common medication classes. The people who get in trouble with NAD+ are almost always the people who skip the due diligence: high doses without supervision, active cancer, or stacking with incompatible medications.
Common NAD+ Side Effects
These are the mild, transient effects most users encounter. Usually dose-related and usually resolve within days to weeks.
Serious NAD+ Side Effects
Uncommon but important. Stop and seek medical evaluation if these appear.
Liver Toxicity (Dose-Dependent)
High-dose nicotinamide (250mg+ in some animal and human reports) has been associated with elevated liver enzymes and, at significantly higher intakes, hepatotoxicity. The effect is reversible upon stopping. Niacin at sustained high doses can also raise liver enzymes. NR and NMN have shown minimal hepatic effects in trials. This is one of the reasons "more is not better" with NAD+ precursors.
Low Platelet Count (Thrombocytopenia)
Some NAD+ precursor trials have reported modest reductions in platelet count, typically at higher doses. Usually reversible after stopping. Worth knowing about if you are on blood thinners, planning surgery, or have a pre-existing low platelet condition.
Severe Blood Pressure Drops
Doses above 2 grams of NAD+ precursors per day have been linked to meaningful blood pressure reductions, which is often the therapeutic goal for some patients but a risk for people already on antihypertensive medications. Symptoms of hypotension: dizziness, lightheadedness, blurry vision, fainting.
Chest Pain or Pressure During IV Infusion
Rapid IV NAD+ infusion can cause a transient feeling of chest pressure, tightness, or even burning that patients sometimes describe as "bone pain" spreading through the chest and abdomen. This is typically infusion-rate-dependent and resolves when the drip is slowed. Severe or persistent chest pain during infusion requires immediate stop and evaluation.
Severe Allergic Reaction (Anaphylaxis, Angioedema)
Rare. Symptoms: swelling of face, lips, tongue, or throat, difficulty breathing, severe rash, fainting, rapid heartbeat. Stop immediately and call emergency services.
Rapid Heart Rate or Palpitations
Reported occasionally with IV and injectable NAD+, often tied to infusion speed. Usually transient. Persistent palpitations warrant evaluation.
Sirtuin Suppression (Nicotinamide Specifically)
Not a traditional side effect, but worth flagging. Nicotinamide at high doses inhibits sirtuins, the longevity enzymes NAD+ supplementation is usually aiming to activate. This makes nicotinamide a counterproductive choice for anti-aging-focused supplementation at higher doses, even though it raises NAD+ levels.
Side Effects by Delivery Method
The form you take changes the risk profile significantly.
The general rule: oral precursors are the gentlest and cheapest. Injectable and IV forms produce faster and more intense results but trade in a more pronounced acute side-effect pattern. Slow IV infusion rates (90 minutes or more for a 500-1,000mg dose) substantially reduce the chest pressure and flushing.
NAD+ Side Effects by Precursor
All NAD+ precursors raise NAD+ levels, but their side effect profiles are not interchangeable.
Niacin (Vitamin B3, Nicotinic Acid)
Cheap, widely available, and the original NAD+ precursor. Flushing is universal at doses above 50mg/kg, typically appearing 30 minutes after ingestion: warm, red, tingling skin, especially on the face, neck, and upper chest. Not harmful, but uncomfortable. Extended-release niacin reduces flushing but increases the risk of liver enzyme elevation. Best avoided at high doses unless under medical supervision for cholesterol management.
Nicotinamide (Niacinamide)
The amide form of niacin, no flushing. But it inhibits sirtuins at high doses, which defeats the longevity purpose most people take NAD+ for. Also associated with elevated liver enzymes at sustained high intakes. Despite being cheap and flush-free, most longevity clinicians do not recommend it as the primary NAD+ precursor.
Nicotinamide Riboside (NR)
Widely studied in humans. Minimal flushing, no significant liver concerns at standard doses (250-600mg daily). Most common reported side effects: mild GI upset, fatigue in the first 1-2 weeks, occasional calf cramps. Conze et al. 2019 showed NR at 300-1,000mg daily was safe over 6-8 weeks with no serious adverse events.
Nicotinamide Mononucleotide (NMN)
Similar safety profile to NR at equivalent doses. Yi et al. 2023 multicenter trial tested 300-900mg daily and found dose-dependent NAD+ elevation with no significant safety concerns. Most common mild effects: nausea, loose stools, occasional headache, rare reports of skin burning sensations and low platelets in a few trials.
Direct NAD+ (IV, Injectable, Liposomal)
Bypasses precursor conversion. Side effects are primarily related to infusion/injection speed and dose: flushing, chest pressure during IV, injection site burning with SQ, occasional nausea. Generally well tolerated when administered slowly and at moderate doses.
The NAD+ and Cancer Question
This deserves direct treatment because the answer is often misreported.
NAD+ does not cause cancer. Multiple reviews have concluded that NAD+ supplementation does not initiate malignant transformation in healthy cells. In fact, NAD+ supports DNA repair through PARP enzymes and sirtuin-driven genome maintenance, which is protective against cancer initiation.
NAD+ can theoretically support the survival of cancer cells that already exist. This is the concern worth understanding. Cancer cells, like all cells, use NAD+ for energy and proliferation. In some studies, elevated NAD+ has been linked to reduced effectiveness of certain chemotherapy drugs, and some cancer medications work specifically by depleting NAD+. This means:
- NAD+ supplementation is generally not recommended during active chemotherapy without specific oncologist guidance
- People with a personal or family history of cancer should discuss NAD+ use with their oncologist before starting
- Stacking NAD+ with senolytics (compounds that clear senescent cells) may mitigate some theoretical risk around supporting aged or dysfunctional cells
The practical reading: NAD+ is not contraindicated for cancer survivors in remission, but it is a decision that benefits from medical input rather than being made based on a supplement marketing page.
NAD+ Drug Interactions: 7 Medication Classes to Know
This is where NAD+ gets real for a lot of users. The compound interacts with more medications than most people realize.
1. Diabetes Medications (Insulin, Sulfonylureas, Metformin)
NAD+ can improve insulin sensitivity, which is often a benefit, but combined with insulin or sulfonylureas can increase the risk of hypoglycemia. Blood glucose monitoring is important if you start NAD+ while on diabetes medications. Your prescriber may need to adjust your insulin or sulfonylurea dose.
2. Blood Pressure Medications
NAD+ boosters, especially at doses above 2 grams daily, can significantly lower blood pressure. Combined with antihypertensive medications, this can cause hypotension (dizziness, lightheadedness, fainting). Monitor your blood pressure when starting and during dose escalation.
3. Cancer Treatments (Chemotherapy, Certain Targeted Therapies)
Some cancer medications work specifically by reducing NAD+ in tumor cells. Supplementing NAD+ can blunt this mechanism. NAD+ boosters may also bind to or interfere with certain targeted therapies. As a general rule, avoid NAD+ supplementation during active chemotherapy unless your oncologist specifically approves it.
4. Blood Thinners (Warfarin/Coumadin, Direct Oral Anticoagulants)
Niacin in particular can affect warfarin metabolism, causing critically elevated INR in documented case reports. Direct oral anticoagulants (apixaban, rivaroxaban) have fewer reported interactions but the data is limited. If you are on a blood thinner, tell your prescriber before starting any NAD+ precursor, and do not add high-dose niacin without close monitoring.
5. Antioxidants (Vitamin C, Vitamin E, Glutathione)
Stacking NAD+ with antioxidants can amplify both benefits and side effects. Specifically, flushing, nausea, calf cramps, skin itching, headaches, and GI discomfort can be intensified. Lower starting doses of each compound are usually advisable when combining.
6. Antidepressants
Research on NAD+ and antidepressant interaction is limited. There is evidence that antidepressants may affect niacin and NAD+ metabolism in patients with poor dietary intake. Mixing is not contraindicated but should be discussed with a prescriber, particularly for SSRIs and tricyclic antidepressants.
7. Melatonin
Taking NAD+ and melatonin together at night can amplify sedation and next-morning grogginess. NAD+ in the evening can also interfere with melatonin's sleep-onset effect for some users. Most people find NAD+ tolerance is better in the morning.
Who Should Avoid NAD+ Supplementation
Certain groups should not start NAD+ without clear physician guidance.
- Active cancer or current chemotherapy: Discuss with oncologist before any use
- Personal or family history of cancer: Physician guidance recommended before starting
- Pregnancy and breastfeeding: No adequate safety data; avoid
- Active liver disease: Nicotinamide and niacin at high doses are contraindicated; NR and NMN with caution under medical supervision
- Severe kidney disease: Requires specialist input
- Children and adolescents: No reason to supplement at this age; endogenous NAD+ is at or near peak
- People on blood thinners or complex cardiac medication regimens: Prescriber oversight before starting
- People with active eating disorders: NAD+ can blunt appetite in some users; not appropriate in this context
- Severe hypotension or orthostatic issues: Blood pressure effects can worsen symptoms
[Image #1]
7 NAD+ Warning Signs You Should Not Ignore
Most NAD+ side effects are mild and pass within hours. A small set are not, and they tend to be missed because users assume the supplement is "just NAD+" and therefore harmless. Stop dosing and contact a clinician if any of the following appear.
- Persistent nausea or vomiting that lasts more than a day. Acute nausea during an IV is expected when the drip runs too fast. Nausea that continues 24 hours after you have stopped dosing is not normal and can signal liver irritation, dehydration, or an oral precursor reaching too high a peak dose.
- Severe or recurring headaches. Mild head pressure during an IV is common. Pounding, blurred-vision, or one-sided headaches that linger after the infusion suggest blood pressure changes or vascular irritation, not "just detox."
- New or worsening skin flushing, rash, or hives. Niacin-style flushing fades in 30 to 60 minutes. A rash that persists or spreads can be an allergy to the formulation, a preservative, or a contaminant from an unverified compounding source.
- Unusual fatigue, weakness, or "crash" feeling. NAD+ supplementation is supposed to do the opposite. Sudden fatigue after a session or daily dose can point to electrolyte shifts, low blood pressure, or a paradoxical inflammatory response.
- Elevated liver enzymes on routine bloodwork. High-dose niacin and some NAD+ precursor formulations have caused ALT and AST rises in case reports. If you are dosing daily, ask for a liver panel after 8 to 12 weeks.
- Dizziness or lightheadedness, especially when standing. Suggests an exaggerated blood pressure drop. Common in users already on antihypertensives and a reason to start low and slow.
- Allergic reaction signs: throat tightness, lip or face swelling, wheezing. Rare but real. Stop immediately, do not "push through," and seek urgent care.
The pattern that matters is severity plus persistence. A symptom that vanishes within an hour is almost always tolerable. A symptom that lingers beyond a day, or returns with every dose, is a signal to pause and rule out something other than expected side effects.
How Long NAD+ Side Effects Typically Last
Duration is one of the most-asked questions and one of the least-answered. Here is what published case data, clinical experience, and patient reporting tend to show.
- IV NAD+ flushing, chest pressure, head pressure: Peaks during the infusion. Fades within 30 to 60 minutes after the drip slows or stops. Almost always resolves the same day.
- Subcutaneous or IM injection site burning and redness: Burning is worst during the injection and the next 5 to 10 minutes. Local redness or small nodules can persist 24 to 48 hours and should not recur in the same spot.
- Oral NMN or NR nausea and stomach upset: Usually appears within an hour of the dose and resolves in 2 to 4 hours. Taking the dose with food fixes most cases.
- Niacin-precursor flushing: Onset 15 to 30 minutes after dosing, peaks at 45 minutes, resolves by 90 minutes. Does not require treatment.
- Headaches and fatigue from too-high doses: Can linger 12 to 24 hours after a dose. If they recur on every dose, the dose is too high or the form is wrong for you.
- Liver enzyme elevations: Develop over weeks and normalize within 4 to 8 weeks after stopping the offending product, in most published case reports.
If a side effect lasts longer than what you see above, treat it as a signal to stop the protocol and get evaluated, not as something to wait out. For dose-by-form starting points that minimize these reactions in the first place, see our NAD+ dosage guide, and if oral has been the issue our NAD+ injections protocol page covers how subcutaneous dosing changes the side-effect profile.
How to Minimize NAD+ Side Effects
Most people can reduce or eliminate common side effects with a few practical adjustments.
For Oral Precursors (NMN, NR)
- Start low, titrate up: 125-250mg daily for 1-2 weeks before increasing to 500-1,000mg
- Take with breakfast: Reduces nausea and aligns with the natural daytime NAD+ oscillation
- Add TMG (500-1,000mg daily): A methyl donor that prevents the plateau caused by methyl pool depletion around week 6-8
- Hydrate: At least 2-3L water daily reduces headache and cramping risk
- Take a break: Cycling 8 weeks on / 1-2 weeks off reduces sirtuin desensitization and methyl donor drain
For Subcutaneous Injection
- Let the vial reach room temperature for 15-30 minutes before injecting to reduce sting
- Inject slowly over 20-30 seconds rather than pushing quickly
- Rotate sites between abdomen, thigh, and upper arm; avoid scar tissue
- Apply gentle pressure for 30-60 seconds after injection to minimize burning
- Start with a lower dose (100-200mg) for the first few injections before scaling up
- Inject in the morning to reduce insomnia risk from the energy spike
For IV Infusion
- Slow the drip rate: 90 minutes or longer for a 500-1,000mg infusion sharply reduces flushing and chest pressure
- Eat a light meal 30-60 minutes beforehand to reduce nausea
- Hydrate aggressively the day before and day of infusion
- Communicate with the clinician: Ask to slow the drip if chest pressure or nausea appears, this usually resolves the symptoms within minutes
- Space out sessions: Weekly or bi-weekly rather than daily initial protocols
- Choose an experienced provider: Clinicians who regularly administer NAD+ IV know how to adjust rate, temperature, and patient comfort
For Niacin Flushing Specifically
- Take with food: Reduces absorption peak and flushing intensity
- Start with low dose: 100mg and increase gradually
- Aspirin 325mg 30 minutes before: Reduces flushing in most people (check with your doctor)
- Switch to sustained-release niacin only under medical supervision due to higher liver risk
When to Call Your Doctor or Go to the ER
Call your doctor for:
- Persistent nausea or vomiting beyond 48 hours
- Progressive fatigue that does not improve
- Recurrent flushing with no clear trigger
- Persistent muscle cramps or weakness
- Unexplained bruising or easy bleeding (possible low platelets)
- Unusual fatigue combined with yellowing of skin or eyes (possible liver involvement)
- Blood pressure readings consistently below your usual baseline
Go to the ER or call emergency services for:
- Severe chest pain or pressure during or after NAD+ infusion that does not resolve quickly
- Swelling of face, lips, tongue, or throat, or trouble breathing (possible anaphylaxis)
- Sudden severe abdominal pain radiating to the back
- Fainting or severe dizziness
- Rapid irregular heartbeat that does not settle
- Severe allergic reaction with rash, rapid pulse, and breathing difficulty
Injection Site Burning: What's Normal, What's Not
The most common complaint from people using subcutaneous NAD+.
NAD+ has an acidic pH (around 3-4), which causes a sharp stinging or burning sensation when injected into subcutaneous tissue. For most people it is brief (30 seconds to a few minutes) and fades after the injection is complete. This is expected and does not indicate injury.
What is concerning: Burning that persists for hours, spreads, or produces significant redness, swelling, or warmth at the injection site. Redness that darkens to bruising. Lumps or nodules that form and do not resolve in days. Any of these should prompt clinical evaluation and may indicate a local reaction or infection.
How to reduce the burn:
- Room-temperature vial (not straight from the fridge)
- Slow injection over 20-30 seconds
- Gentle massage or cold compress post-injection
- Rotate sites each injection
- Ensure the NAD+ is properly pH-buffered (quality vendors use buffered formulations)
"Bone Pain" From IV NAD+: Real or Myth?
Some patients report a sensation during IV NAD+ infusion that is often described as "bone pain," chest pressure, or intense internal discomfort. It is real, but it is not actually pain in the bones.
The sensation is caused by rapid systemic absorption of NAD+, which triggers vasodilation and neural activation. It feels like pressure, warmth, or pulling in the chest, abdomen, or upper arms. It typically appears 15-45 minutes into an infusion that is running too fast, and resolves within minutes when the drip rate is slowed.
If this happens during your infusion, tell the clinician and ask to slow the rate. A well-paced NAD+ infusion (90 minutes or more for 500-1,000mg) should not produce this sensation in most patients.
Side effect profiles differ across delivery routes. For a comparison of the gentler subcutaneous NAD+ peptide route versus IV NAD+, see our NAD+ peptide guide.
